Lipopolysaccharide (LPS)

🦠 Lipopolysaccharide, Arthritis & Inflammatory diseases

What Is LPS?

Lipopolysaccharide (LPS) is a large molecule that forms part of the outer membrane of gram-negative bacteria, including Porphyromonas gingivalis, Escherichia coli, Fusobacterium nucleatum, and many gut and oral species.
It acts as an endotoxin — a potent immune trigger that the body interprets as a signal of bacterial invasion.

When LPS enters the bloodstream, it binds primarily to Toll-like receptor 4 (TLR4) on immune cells such as macrophages and dendritic cells. This sets off an intense inflammatory cascade involving NF-κB, TNF-α, IL-1β, and IL-6, along with matrix metalloproteinases (MMPs) that break down cartilage and connective tissue.
This process contributes to joint inflammation, cartilage erosion, and systemic inflammatory load — all major drivers of inflammatory diseases like arthritis.

Relevance

These mechanisms above have been implicated not only in inflammatory arthritis, but across a wide range of chronic inflammatory and autoimmune conditions such as;

• Inflammatory arthritis (RA, PsA, AS, axSpA)

• Inflammatory bowel disease

• Metabolic syndrome & insulin resistance

• Cardiovascular disease

• Neuroinflammatory conditions

• Autoimmune conditions more broadly

How LPS Contributes to Inflammation

1. Immune System Activation.
   LPS activates the innate immune system through TLR4, mimicking infection even when no live bacteria are present.
   This can sustain chronic, low-grade inflammation — sometimes called metabolic endotoxemia.

2. Joint Inflammation & Cartilage Damage.
   In animal studies, direct injection of LPS into joints induces arthritis-like inflammation.
   Elevated serum LPS levels have been found in patients with rheumatoid arthritis (RA), psoriatic arthritis, and osteoarthritis (OA), correlating with disease severity and CRP levels.

3. Amplified Cytokine Production.
   LPS increases the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), which not only worsen joint inflammation but also promote systemic insulin resistance, fatigue, and bone loss.

4. TLR4–MMP Connection.
   The TLR4 pathway upregulates MMP-1, MMP-3, and MMP-13, enzymes that degrade cartilage collagen — a mechanism observed in both human and animal arthritis models.

Sources of LPS in the Body

🦷 Leaky Gums — A Hidden Source of Inflammation

Just like a “leaky gut,” leaky gums can be a major entry point for bacterial endotoxins into the bloodstream.
Periodontitis (gum disease) is dominated by gram-negative bacteria such as Porphyromonas gingivalis and Fusobacterium nucleatum, both of which produce high levels of LPS.

When gum tissues are inflamed, the barrier between the mouth and bloodstream becomes porous. Each time you brush, chew, or floss inflamed gums, LPS and bacteria can translocate into circulation, creating a pulse of systemic inflammation.
This oral–systemic connection has been strongly linked to rheumatoid arthritis, atherosclerosis, type 2 diabetes, and Alzheimer’s disease.

🔬 Key Research Findings

• Hitchon et al., 2010 (Arthritis Research & Therapy) – Found elevated serum LPS levels in rheumatoid arthritis patients compared to controls, correlating with CRP and IL-6.

• Tobón-Velasco et al., 2014 (Frontiers in Cellular Neuroscience) – Described how chronic exposure to LPS drives systemic inflammation and oxidative stress, contributing to neuroinflammatory and autoimmune disorders.

• Huang et al., 2021 (Frontiers in Immunology) – Showed that TLR4 signaling in synovial fibroblasts mediates cartilage degradation and osteoarthritis progression.

• Scher et al., 2012 (Arthritis & Rheumatism) – Identified P. gingivalis–related oral dysbiosis and citrullination as key links between gum disease and rheumatoid arthritis.

• Vieira et al., 2019 (Clinical and Experimental Immunology) – Demonstrated that metabolic endotoxemia (from gut LPS) predicts higher inflammatory scores in arthritis and obesity.

🔧 How to Reduce LPS Load and Inflammation

1. Strengthen Gut Barrier Function

• Eat fiber-rich, plant-based foods.

• Include polyphenols (berries, green tea, pomegranate, turmeric).

• Avoid alcohol, emulsifiers, and ultra-processed foods that damage the gut lining.

2. Improve Oral Health

• Brush, floss, and use natural antimicrobial rinses daily.

• Treat gum inflammation and infection early.

• See the Oral Health for full details.

3. Support Beneficial Gut Bacteria

• Consume prebiotic foods (onions, garlic, legumes, oats, green bananas).

• Include fermented foods like sauerkraut or kefir (if tolerated).

• Consider probiotics targeting Lactobacillus and Bifidobacterium species.

4. Reduce Sugar and Processed Fat Intake

• High-fat, high-sugar meals acutely raise blood LPS within hours.

• Replace with whole foods, omega-3 fats, and resistant starch.

5. Anti-inflammatory Lifestyle Factors

• Prioritize sleep, manage stress, and exercise regularly — all shown to improve gut barrier integrity and lower LPS burden.

📘 Summary

Lipopolysaccharide (LPS) is not merely a bacterial by-product — it is a potent inflammatory driver capable of perpetuating chronic inflammation, joint pain, immune dysregulation, and tissue damage.

Leaky gut and leaky gums are major modern sources of LPS exposure, linking oral and gut health directly to inflammatory arthritis, metabolic disease, and cardiovascular risk.

Importantly, LPS burden depends not only on barrier integrity, but also on the abundance of LPS-producing bacteria. Reducing pathogenic microbial load while supporting a resilient, diverse microbiome may help lower inflammatory signalling — even when minor permeability is present.

Strategies that support gut and oral barriers, promote microbiome balance, and limit LPS exposure help reduce inflammation at its root and improve outcomes across a range of chronic inflammatory conditions.

As part of my my own daily protocols, I apply techniques that support microbial balance and reduce LPS burden.